Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1988 | 12-1987 | 12-1986 | 12-1985 | 12-1984 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,211 | 1,537 | 4,368 | 2,009 | 34 |
| Marketable Securities | 312 | 464 | 2,277 | 500 | 1 |
| Receivables | 0 | 0 | 250 | 0 | 0 |
| Other current assets | 36 | 126 | 32 | 83 | 8 |
| TOTAL | $1,560 | $2,127 | $6,926 | $2,592 | $43 |
| Non-Current Assets | |||||
| PPE Net | 102 | 154 | 185 | 126 | 101 |
| Other Non-Current Assets | 12 | 217 | 2 | 4 | 0 |
| TOTAL | $114 | $371 | $187 | $130 | $101 |
| Total Assets | $1,674 | $2,497 | $7,113 | $2,722 | $144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,254 | 228 | 230 | 662 | 213 |
| Accrued Expenses | 109 | 215 | 166 | 0 | 0 |
| Other current liabilities | 5 | 3 | 49 | 46 | 173 |
| TOTAL | $1,368 | $446 | $395 | $1,310 | $409 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 26 | 6 | 0 | 0 | 0 |
| TOTAL | $457 | $6 | $55 | $91 | $N/A |
| Total Liabilities | $1,825 | $452 | $450 | $1,401 | $535 |
| Shareholders' Equity | |||||
| Common Shares | 116 | 101 | 98 | 84 | 75 |
| Retained earnings | -29,437 | -21,142 | -15,042 | -12,034 | -8,723 |
| Other shareholders' equity | -107 | -799 | 0 | 0 | 0 |
| TOTAL | $-151 | $2,045 | $6,663 | $1,321 | $-391 |
| Total Liabilities And Equity | $1,674 | $2,497 | $7,113 | $2,722 | $144 |